Cargando…
A CRISPR/Cas9 Functional Screen Identifies Rare Tumor Suppressors
An enormous amount of tumor sequencing data has been generated through large scale sequencing efforts. The functional consequences of the majority of mutations identified by such projects remain an open, unexplored question. This problem is particularly complicated in the case of rare mutations wher...
Autores principales: | Katigbak, Alexandra, Cencic, Regina, Robert, Francis, Sénécha, Patrick, Scuoppo, Claudio, Pelletier, Jerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159885/ https://www.ncbi.nlm.nih.gov/pubmed/27982060 http://dx.doi.org/10.1038/srep38968 |
Ejemplares similares
-
Inducible Genome Editing with Conditional CRISPR/Cas9 Mice
por: Katigbak, Alexandra, et al.
Publicado: (2018) -
Repurposing CRISPR/Cas9 for in situ functional assays
por: Malina, Abba, et al.
Publicado: (2013) -
Protospacer Adjacent Motif (PAM)-Distal Sequences Engage CRISPR Cas9 DNA Target Cleavage
por: Cencic, Regina, et al.
Publicado: (2014) -
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A
por: Chu, Jennifer, et al.
Publicado: (2016) -
CRISPR/Cas9 screening using unique molecular identifiers
por: Schmierer, Bernhard, et al.
Publicado: (2017)